Asthma & COPD Market, By Drug Type (Bronchodilators, Anti-Inflammatories, Combination Therapies), By Disease Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.

Restraints of the Global Asthma and COPD Market

Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.

Key features of the study:

This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global asthma and COPD market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Asthma and COPD Market, By Drug Type:
- Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
- Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
- Combination Therapies
Global Asthma and COPD Market, By Disease Type:
- Asthma
- COPD
Global Asthma and COPD Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
Global Asthma and COPD Market, By Geography:
- North America
By Drug Type
- Bronchodilators
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
  - Anticholinergics
- Anti-Inflammatories
  - Inhaled Corticosteroids
  - Anti-Leukotriene
  - Monoclonal Antibodies
- Combination Therapies
By Disease Type
- Asthma
- COPD
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Country:
- U.S.
- Canada
- Europe
By Drug Type
- Bronchodilators
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
  - Anticholinergics
- Anti-Inflammatories
  - Inhaled Corticosteroids
  - Anti-Leukotriene
  - Monoclonal Antibodies
- Combination Therapies
By Disease Type
- Asthma
- COPD
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
By Drug Type
- Bronchodilators
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
  - Anticholinergics
- Anti-Inflammatories
  - Inhaled Corticosteroids
  - Anti-Leukotriene
  - Monoclonal Antibodies
- Combination Therapies
By Disease Type
- Asthma
- COPD
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
By Drug Type
- Bronchodilators
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
  - Anticholinergics
- Anti-Inflammatories
  - Inhaled Corticosteroids
  - Anti-Leukotriene
  - Monoclonal Antibodies
- Combination Therapies
By Disease Type
- Asthma
- COPD
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
By Drug Type
- Bronchodilators
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
  - Anticholinergics
- Anti-Inflammatories
  - Inhaled Corticosteroids
  - Anti-Leukotriene
  - Monoclonal Antibodies
- Combination Therapies
By Disease Type
- Asthma
- COPD
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
By Drug Type
- Bronchodilators
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
  - Anticholinergics
- Anti-Inflammatories
  - Inhaled Corticosteroids
  - Anti-Leukotriene
  - Monoclonal Antibodies
- Combination Therapies
By Disease Type
- Asthma
- COPD
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Country/Region:
- Central Africa
- South Africa
- North Africa
Company Profiles
- AstraZeneca PLC*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
- Novartis AG
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Verona Pharma plc
- Regeneron Pharmaceuticals, Inc.
- Boehringer Ingelheim GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4002

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description

Market Definition and Scope
- Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Disease Type
Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis

4. Global Asthma and COPD Market, By Drug Type, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Bronchodilators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Short Acting Bronchodilators
- Long Acting Bronchodilators
- Anticholinergics
- Anti-Inflammatories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Inhaled Corticosteroids
- Anti-Leukotriene
- Monoclonal Antibodies
- Combination Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends

5. Global Asthma and COPD Market, By Disease Type, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- COPD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Asthma and COPD Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Drug Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Asthma and COPD Market, By Regions, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

8. Competitive Landscape

Company Profiles

AstraZeneca PLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Verona Pharma plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Regeneron Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

9. Section

References
Research Methodology
About us and Sales Contact

Asthma & COPD Market, By Drug Type (Bronchodilators, Anti-Inflammatories, Combination Therapies), By Disease Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028